Autologous Noncryopreserved Hematopoietic Stem Cell Transplant With CEAM as a Modified Conditioning Regimen in Patients With Hodgkin Lymphoma: A Single-center Experience With a New Protocol-Reference-Cited by-同舟云学术

Autologous Noncryopreserved Hematopoietic Stem Cell Transplant With CEAM as a Modified Conditioning Regimen in Patients With Hodgkin Lymphoma: A Single-center Experience With a New Protocol

Published:2012-04-01 Issue:2 Volume:10 Page:163-167
ISSN:1304-0855
Container-title:Experimental and Clinical Transplantation
language:
Short-container-title:Exp Clin Transplant

Author:

Ramzi Mani,Mohamadian Mohsen,Vojdani Reza,Dehghani Mehdi,Nourani Habib,Zakerinia Maryam,Haghighinejad Hoorvash

Publisher

Baskent University

Subject

Transplantation

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and safety outcomes of BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) versus CEM (Carboplatin, Etoposide, Melphalan) in lymphoma patients as a conditioning regimen before autologous hematopoietic cell transplantation;BMC Cancer;2024-08-13

2. Non-cryopreserved Peripheral Stem Cell Autograft for Multiple Myeloma and Lymphoma in Countries with Low Resources;Handbook of Stem Cell Therapy;2022

3. Non-cryopreserved Peripheral Stem Cell Autograft for Multiple Myeloma and Lymphoma in Countries with Low Resources;Handbook of Stem Cell Therapy;2022

4. The outcome of relapsed/refractory hodgkin's lymphoma patients post autologous bone marrow transplantation in a Baghdad Medical City Complex Center;Iraqi Journal of Hematology;2021

5. Comparison of outcomes of two non-BCNU-containing conditioning regimens used in autologous stem cell transplantation for relapsed/refractory lymphoma;memo - Magazine of European Medical Oncology;2020-05-25